EUCTR2009-017943-32-BE进行中（未招募）不适用
Study of the combination of gemcitabine, cetuximab and radiotherapy in patients with head and neck cancer - RAGE
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Written and signed informed consent
- •Histologically confirmed squamous cell carcinoma of the head and neck which qualifies for definitive treatment with chemoradiation
- •Life expectancy of at least 12 weeks
- •Age > 18 years
- •Performance status of 0 or 1 according to the World Health Organization (WHO)
- •Adequate hematologic, cardiac, pulmonary, renal and liver function
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Pregnant or lactating women or women of childbearing potential without adequate contraceptive measures.
- •Known brain or leptomeningeal metastasis
- •Other serious medical conditions
- •Congestive heart failure, uncontrolled angina pectoris, uncontrolled hypertension or uncontrolled arrhythmia
- •Active infection
- •History of significant neurologic or psychiatric disorders
- •Known hypersensitivity reactions to cetuximab or gemcitabine or one of the excipients.
- •Altered fractionation radiotherapy.
- •Prior radiotherapy and/or chemotherapy (except as induction chemotherapy) within 6 months before enrolment
研究者
相似试验
已完成
2 期
A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer.on-small cell lung cancerJPRN-C000000135Institute of Biomedical Research and Innovation40
已完成
1 期
PhaseI study of the combination of gemcitabine, cisplatin and S-1 in advanced biliary tract canceradvanced biliary tract cancerJPRN-UMIN000006548ational Cancer Center Hospital24
已完成
不适用
A combination phase I/II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancerpreviously untreated elderly non-small cell lung cancerJPRN-C000000072West Japan Oncology Group25
未知
1 期
Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerPreaviously untreated advanced advanced squamous cell lung cancerJPRN-C000000439Department of Respiratory Medicine of Kyoto University Hospital32
已完成
不适用
Phase 2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerung squamous cell carcinomaJPRN-UMIN000004833First Department of Surgery, Hamamatsu University School of Medicine25